An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma

被引:40
|
作者
Li, Meng [1 ,2 ]
Zhang, Lixing [2 ]
Ge, Chao [2 ]
Chen, Lijuan [1 ,2 ]
Fang, Tao [2 ]
Li, Hong [2 ]
Tian, Hua [2 ]
Liu, Junxi [3 ,4 ]
Chen, Taoyang [5 ]
Jiang, Guoping [6 ]
Xie, Haiyang [6 ]
Cui, Ying [7 ]
Yao, Ming [2 ]
Li, Jinjun [2 ]
机构
[1] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Shanghai 200433, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China
[3] Chinese Acad Sci, Lanzhou Inst Chem Phys, Key Lab Chem Northwestern Plant Resources, Lanzhou 730000, Peoples R China
[4] Chinese Acad Sci, Lanzhou Inst Chem Phys, Key Lab Fornatural Med Gansu Prov, Lanzhou 730000, Peoples R China
[5] Qi Dong Peoples Hosp, Qi Dong Liver Canc Inst, Qi Dong, Jiangsu, Peoples R China
[6] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gen Surg, Hangzhou 310003, Zhejiang, Peoples R China
[7] Guangxi Med Univ, Canc Inst Guangxi, Nanning, Peoples R China
基金
中国国家自然科学基金;
关键词
isocorydine; IGF2BP3; cancer stem cell; CD133; hepatocellular carcinoma; MESSENGER-RNA; SIDE-POPULATION; LIQUID-CHROMATOGRAPHY; MULTIDRUG-RESISTANCE; EFFLUX PUMP; RAT PLASMA; STEM-CELLS; CANCER; PROGNOSIS; CHEMORESISTANCE;
D O I
10.18632/oncotarget.4438
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In our previous studies, we reported that CD133(+) cancer stem cells (CSCs) were chemoresistant in hepatocellular carcinoma (HCC) and that isocorydine treatment decreased the percentage of CD133(+) CSCs. Here, we found that a derivative of isocorydine (d-ICD) inhibited HCC cell growth, particularly among the CD133(+) subpopulation, and rendered HCC cells more sensitive to sorafenib treatment. d-ICD inhibited IGF2BP3 expression in a time-dependent manner, and IGF2BP3 expression negatively correlated with d-ICD-induced growth suppression. IGF2BP3 overexpression enriched the CD133(+) CSC subpopulation in HCC, enhanced tumor sphere formation and suppressed the cytotoxic effects of sorafenib and doxorubicin. The expression of drug resistance-related genes, including ABCB1 and ABCG2, and the CSC marker CD133 expression was increased after IGF2BP3 overexpression. The significance of these observations was underscored by our findings that high IGF2BP3 expression predicted poor survival in a cohort of 236 patients with HCC and positively correlated with ABCG2 and CD133 expression in vivo. These results suggested that the d-ICD may inhibit HCC cells growth by IGF2BP3 decrease and that IGF2BP3 may serve as a therapeutic target for HCC.
引用
收藏
页码:25149 / 25160
页数:12
相关论文
共 50 条
  • [31] m6A reader IGF2BP3 contributes to gefitinib resistance in lung adenocarcinoma cells by modulating SNAI2 expression
    Takatsuka, Risa
    Suzuki, Ryusuke
    Terashima, Minoru
    Suphakhong, Kusuma
    Takino, Takahisa
    Kawashiri, Shuichi
    Suzuki, Takeshi
    GENE REPORTS, 2025, 38
  • [32] Increased IGF2BP3 expression promotes the aggressive phenotypes of colorectal cancer cells in vitro and vivo
    Xu, Weimin
    Sheng, Yaru
    Guo, Yuegui
    Huang, Zhenyu
    Huang, Yiji
    Wen, Dongpeng
    Liu, Chen-Ying
    Cui, Long
    Yang, Yili
    Du, Peng
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (10) : 18466 - 18479
  • [33] IGF2BP3-NRF2 axis regulates ferroptosis in hepatocellular carcinoma
    Lu, Zhihua
    Yang, Hao
    Shao, Yuting
    Sun, Wensheng
    Jiang, Yuanhui
    Li, Jie
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 627 : 103 - 110
  • [34] LINC00467 promotes cell proliferation and metastasis by binding with IGF2BP3 to enhance the mRNA stability of TRAF5 in hepatocellular carcinoma
    Jiang, Wenjin
    Cheng, Xueling
    Wang, Tao
    Song, Xuepeng
    Zheng, Yanbo
    Wang, Ligang
    JOURNAL OF GENE MEDICINE, 2020, 22 (03):
  • [35] linc01305 promotes metastasis and proliferation of esophageal squamous cell carcinoma through interacting with IGF2BP2 and IGF2BP3 to stabilize HTR3A mRNA
    Huang, Guo-Wei
    Chen, Qian-Qian
    Ma, Chang-Chun
    Xie, Ling-Hui
    Gu, Jiang
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2021, 136
  • [36] A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma
    Yao, XM
    Hu, JF
    Daniels, M
    Shiran, H
    Zhou, XJ
    Yan, HF
    Lu, HQ
    Zeng, ZL
    Wang, QX
    Li, T
    Hoffman, AR
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (02): : 265 - 273
  • [37] IGF2BP3 (IMP3) expression is associated with worse survival in welldifferentiated/dedifferentiated (WD/DD) liposarcoma
    Klingbeil, Kyle D.
    Tang, Jack Pengfei
    Dry, Sarah M.
    Eilber, Fritz C.
    Rao, Dinesh S.
    Kadera, Brian E.
    Kalbasi, Anusha
    CANCER RESEARCH, 2022, 82 (12)
  • [38] Circ_0098823 binding with IGF2BP3 regulates DNM1L stability to promote metastasis of hepatocellular carcinoma via mitochondrial fission
    Jiuliang Yan
    Xiaofeng Wang
    Zongyu Fan
    Yiqing Xu
    Yingzi Zhang
    Yi Liu
    Lei Guo
    Dongli Liu
    Apoptosis, 2024, 29 : 709 - 725
  • [39] Differential expression and clinical significance of IGF2BP3 in peritoneal dialysate of patients with varying duration of peritoneal dialysis
    Shao, Xiaoqi
    Yao, Ling
    Fu, Jiao
    He, Mengmeng
    Zhang, Pei
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (04):
  • [40] Circ_0098823 binding with IGF2BP3 regulates DNM1L stability to promote metastasis of hepatocellular carcinoma via mitochondrial fission
    Yan, Jiuliang
    Wang, Xiaofeng
    Fan, Zongyu
    Xu, Yiqing
    Zhang, Yingzi
    Liu, Yi
    Guo, Lei
    Liu, Dongli
    APOPTOSIS, 2024, 29 (5-6) : 709 - 725